Incorporating the 40-Gene Expression Profile (40-GEP) Test for Poorly Differentiated Cutaneous Squamous Cell Carcinoma (cSCC) Tumors Mitigates Risk Assessment Uncertainty from Histologic Grading. J of Skin 2023, 7 (2), s164. https://doi.org/10.25251/skin.7.supp.164.